🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety and determine the optimal d...
Status
Completed
Location
Royal Brisbane & Women's Hospital
Start Date
2010-09
Trial ID
NCT01189968
Treatments Being Tested
The purpose of this study is to test the safety and determine the optimal d...
Status
Completed
Location
Sydney Cancer Centre
Start Date
2010-09
Trial ID
NCT01189942
Treatments Being Tested
This is a Phase 1b/2 study of paclitaxel plus demcizumab in subjects with p...
Status
Terminated
Location
University of Oklahoma Stephenson Cancer Center
Start Date
2013-08-05
Trial ID
NCT01952249
Treatments Being Tested
A randomized, double-blind, 3-arm (1:1:1) study in subjects with first-line...
Status
Completed
Location
Desert Hematology Oncology Medical Group, Inc.
Start Date
2015-02
Trial ID
NCT02259582
Treatments Being Tested
The purpose of this study is to test the safety and determine the optimal d...
Status
Completed
Location
Royal Prince Alfred Hospital
Start Date
2010-08
Trial ID
NCT01189929
Treatments Being Tested
The purpose of this study is to test the efficacy and safety of an experime...
Status
Completed
Location
Rocky Mountain Cancer Center
Start Date
2016-01
Trial ID
NCT02722954
Treatments Being Tested
This is a randomized, double blind, 3 arm (1:1:1) study in subjects with 1s...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2015-04-20
Trial ID
NCT02289898
Treatments Being Tested
A phase 1 open-label dose escalation study of OMP-21M18 in subjects with pr...
Status
Completed
Location
California Cancer Care
Start Date
2008-08
Trial ID
NCT00744562
Treatments Being Tested